Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
81.55 EUR | +1.87% |
|
-5.04% | -22.21% |
06-26 | Redburn Atlantic Initiates Arkema at Buy | MT |
05-14 | Arkema: collaboration with ProLogium in batteries | CF |
Strengths
- With a P/E ratio at 10.38 for the current year and 9.07 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.21% | 6.5B | - | ||
+2.61% | 99.64B | A- | ||
-11.38% | 59.01B | A- | ||
+75.71% | 48.81B | B | ||
+5.26% | 34.94B | B | ||
+0.61% | 31.15B | A- | ||
+3.47% | 18.62B | B- | ||
+17.33% | 17.44B | C+ | ||
+5.92% | 13.51B | B- | ||
-6.67% | 12.73B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AKE Stock
- V1S Stock
- Ratings Arkema